Aisling Capital Management LP Bridge Bio Pharma, Inc. Transaction History
Aisling Capital Management LP
- $243 Million
- Q3 2024
A detailed history of Aisling Capital Management LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Aisling Capital Management LP holds 6,068,125 shares of BBIO stock, worth $161 Million. This represents 63.58% of its overall portfolio holdings.
Number of Shares
6,068,125
Previous 6,068,125
-0.0%
Holding current value
$161 Million
Previous $154 Million
0.51%
% of portfolio
63.58%
Previous 67.33%
Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
290Shares Held
170MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$669 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$665 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$376 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$330 Million0.01% of portfolio
-
State Street Corp Boston, MA5.96MShares$158 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.93B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...